← Back

Asia Medical & Agricultural Laboratory & Research Center PCL

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides scientific services to the agriculture, food, pharmaceutical, and environment industries in Thailand. It offers one-stop and customized services, including quality, contaminant, and additive testing for meat and meat products, fats and oils, pet food, feedstuffs, aquaculture products, crops, foods, beverages, nutrition labels, product shelf life, food contact materials, water, and ice. The company also provides fertilizer and hazardous substance services, research and development, efficacy and residue testing of pesticides, and testing of modern drugs, cannabis, hemp, herbs, and cosmetics, as well as water, soil, and air quality analysis. Additionally, it offers calibration of instruments and equipment, medical device testing, inspection and certification, and consultation and training services. Founded in 2004 and headquartered in Bangkok, Thailand, it is a subsidiary of Ladprao General Hospital Public Company Limited.

Country
Price · split & dividend adjusted
News & notes moving AMARC.BK
AMARC.BK

Krungsri keeps Buy on AMARC with 3.80 baht target, expects 0.20 baht dividend

Krungsri Securities maintains a Buy rating on Asia Medical and Agricultural Laboratory and Research Center, or AMARC, with a target price of 3.80 baht, based on a DCF valuation at a WACC of 8.1%, implying a 2026 P/E of 11 times. It views the revenue softness in the third quarter of 2026 as a short-term effect of price competition in durian export quality inspection services, expecting total service revenue to fall both year on year from 128 million baht in the third quarter of 2025 and quarter on quarter from 135 million baht in the second quarter of 2026. Meanwhile, 2027 profit has room to return to 8% year-on-year growth on a recovery in service revenue and margin expansion. The company targets instrument calibration service revenue in 2027 to grow at least 50% year on year, accelerating from this year's target of about 25-30% year on year, with calibration services currently accounting for roughly 4% of total service revenue. The company also announced the completion of its share buyback program for financial management, repurchasing a total of 20 million shares, or 4.76% of issued shares, for a total value of 65 million baht, or an average cost of 3.25 baht per share. It is expected to pay a dividend of 0.20 baht per share this year, a dividend yield of about 7%.
AMARC.BK
ทันหุ้น·1dRead more →
AMARC.BK▲

AMARC closes 65 million baht share buyback project, sweeping up 20 million shares

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited, or AMARC, officially closed its share buyback project for financial management on 19 August 2026, having repurchased a total of 20,000,000 shares, representing 4.76 percent of all issued shares, with a total value of 65,052,080 baht. This was in line with the Board of Directors' resolution number 1/2026 on 22 January 2026, which set a maximum budget of 70 million baht and a maximum of 25 million shares, or no more than 5.95 percent. The buyback was executed through the Stock Exchange of Thailand's trading system between 20 February 2026 and 19 August 2026. Going forward, AMARC must dispose of the repurchased shares within three years, counting from the end of the three-month period after the project's completion, and may request an extension of no more than two additional years. If the shares cannot be fully disposed of, the company must reduce its paid-up registered capital by cancelling the repurchased shares that remain unsold.
AMARC.BK ▲
Kaohoon·29dRead more →
AMARC.BK▼

LPH announces first-half profit of 85 million baht, dividend of 0.05 baht

Ladprao Hospital Public Company Limited, or LPH, announced its first-half results for 2026, with net profit attributable to majority shareholders of 85.26 million baht, down 6.16 percent from the same period last year, and total revenue of 1.263 billion baht, down 3.26 percent. Revenue from medical treatment and services, the main income source, stood at 1.013 billion baht, close to the previous year, while revenue from subsidiary AMARC fell 10.93 percent due to an aggressive pricing strategy in export fruit and vegetable testing services. The board of directors approved an interim dividend of 0.05 baht per share, with the record date and ex-dividend date set for 27 August 2026, and payment on 9 September 2026.
LPH.BK ▼AMARC.BK ▼
Share2Trade·32dRead more →
© 2026 MarketDXAsset